Medical/Pharmaceuticals
"Global Innovation Challenge 2023" Inviting Participants in "Living Assistance Robot Contest" Designed to Help People with Disabilities "Walk Independently"
TOKYO, Nov. 10, 2022 /PRNewswire/ -- The Global Innovation Challenge Executive Committee (hereinafter referred to as "GIC Executive Committee") based inTokyo is pleased to announce the "Global Innovation Challenge 2023 Living Assistance Robot Contest" (hereinafter referred to as "GIC Contest") wi...
Ascentage Pharma Announces IND Approval in China for Phase I Study of APG-5918 in Patients with Advanced Solid Tumors or Hematologic Malignancies
SUZHOU, China and ROCKVILLE, Md., Nov. 9, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that its novel inhibitor of the embryonic ectoderm ...
Kintor Pharma Announces Oral Presentation at ASH 2022 Highlighting the Data from Novel Dual c-Myc/GSPT1 Degrader GT19715
SUZHOU, China, Nov. 9, 2022 /PRNewswire/ -- Kintor Pharmaceutical Limited ("KintorPharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced that the results from the novel dual c-Myc/GSPT1 degrader GT19715 have been s...
Monash University Implements Antibody Discovery Application by Utilizing the Berkeley Lights Beacon® Platform
EMERYVILLE, Calif. and MELBOURNE, Australia, Nov. 10, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced Monash University, one ofAustralia's leading universities, has implemented the use of the Berkeley Lights Beacon® system and Opto® Plas...
ALPINION MEDICAL SYSTEMS SHOWCASING THE LATEST INTELLIGENT ULTRASOUND TECHNOLOGY AT RSNA 2022
Unveiling Upgraded Top-Tier 'X-CUBE 90 on GPX' and Debuting Value Console 'X-CUBE 60' Unit Are Among the New-Generation of Diagnostic Ultrasound Systems to Be Demonstrated at the Radiological Society ofNorth America's Annual Medical Exhibition SEOUL, South Korea, Nov. 9, 2022 /PRNewswire/ -- ALP...
Medison Pharma Announces Expansion of the Multi-Territorial Agreement with Immunocore into Latin America
With this latest expansion, Medison's global footprint is now extended across Israel, Central and Eastern Europe, Canada, Asia-Pacific and Latin America, offering patients in international markets improved access to highly innovative therapies. PETACH TIKVAH, Israel, Nov. 9, 2022 /PRNewswire/ --...
TOOsonix announces granted patents for its non-invasive treatments of dermatological conditions
TOOsonix A/S secures intellectual property rights in USA, Europe and China. The patents define methods for non-invasive and real-time image-guided treatment of skin using therapeutic ultrasound. HOERSHOLM, Denmark, Nov. 9, 2022 /PRNewswire/ -- TOOsonix A/S, a pioneer in high intensity focused ul...
Mentice Receives Grant from Sweden's Innovation Agency to Improve Synthetic Image Generation
GOTHENBURG, Sweden, Nov. 9, 2022 /PRNewswire/ -- Mentice has received a 3 million SEK grant from the Swedish government agency for innovation, Vinnova, to improve realism in Mentice virtual reality software environment with a focus on synthetic image generation. Mentice will be a part of a joint ...
Transcenta to Hold 3 Exchange Sessions on Post-SITC Business Update Call & TST003 data release and pipeline development progress update
SUZHOU, China, Nov. 9, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical-stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development, and manufacturing of antibody-based therapeutics, announces that the management ...
Strong business performance in 9M/2022: Exyte increases order intake, sales, and profitability
* Order intake up by more than 25% year-on-year, marking a new 9M-high with €6.5 billion * Sales volume increased by almost 60% to €5.3 billion * Strong increase in sales in all three business segments * Adjusted EBIT increased by 73% to €308 million; adjusted EBITDA rose by 70% to €340 mi...
Axiomtek launches the newest medical grade artificial intelligence computing system - mBOX100
TAIPEI, Nov. 9, 2022 /PRNewswire/ -- Axiomtek – a world-renowned leader relentlessly devoted to the research, development, and manufacturing of innovative and reliable industrial computer products of high efficiency – is pleased to announce the release of themBOX100, a medical-grade edge AI comp...
JW Therapeutics Announces its Cell Immunotherapy Drugs Have Successfully Benefited 300 Patients
SHANGHAI, Nov. 9, 2022 /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced that as ofNovember 8, 2022, its cell immunotherapy drugs (marketed products and...
Siemens Healthineers to demonstrate the remote capabilities of Corindus CorPath GRX Robotic System using Mentice VIST ® Simulator
GOTHENBURG, Sweden, Nov. 9, 2022 /PRNewswire/ -- Mentice, a world leader in simulation solutions for image-guided interventional therapies, announced today that Siemens Healthineers China is showcasing the remote capabilities of the Corindus CorPath GRX Robotic PCI system by using the Mentice VIS...
Together We Build a Malaria-Free World: Fosun Receives IP SHANGHAI Global Communications Corporate Case Best Practice Award
HONG KONG, Nov. 9, 2022 /PRNewswire/ -- On 8 November 2022, we received good news from the 5th China International Import Expo (CIIE): the1st In Shanghai, For the World has announced the recipients of the IP SHANGHAI Global Communications Corporate Case Best Practice Award. The organizing committ...
Smith+Nephew Academy Singapore opens, bringing medical education and digital innovation to healthcare professionals across Asia-Pacific
LONDON, Nov. 9, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the opening of Smith+Nephew (S+N) Academy Singapore, a major medical education and digital innovation centre covering theAsia-Pacific region today, in the presence of Mr Gan Kim ...
TES Pharma Congratulates Intercept Pharmaceuticals on their Presentation of Phase 1 INT-787 Data at the AASLD Meeting and the Initiation of the Phase 2a FRESH Study in Patients with Severe Alcohol-Associated Hepatitis
INT-787 is a selective next generation FXR agonist invented by TES Pharma and licensed to Intercept Pharmaceuticals INT-787 has shown strong anti-fibrotic and anti-inflammatory effects in animal models TES Pharma is dedicated to the identification of novel therapeutic targets and the discovery ...
Himalaya Therapeutics Announces Highlights of Recent Clinical Progress
* Mecbotamab vedotin (BA3011) Phase 2 part 1 interim results in NSCLC continue to show antitumor activity with additional patients enrolled * HTBA3011 Undifferentiated Pleomorphic Sarcoma (UPS) enrollment in Phase 2 part 2 of study anticipated to begin by year-end * CAB-CTLA-4 (HTBA3071) Pha...
Insilico Medicine Signs Strategic Research Collaboration with Sanofi worth up to $1.2 Billion
Agreement includes aggregate upfront and target nomination fees of up to $21.5 million for up to 6 targets, and additional R&D and sales milestones plus tier-based mid-single- to low double-digit royalties. New York , Nov. 8, 2022 /PRNewswire/ -- Insilico Medicine, a clinical stage artificial in...
Amorepacific publishes its findings on dietary restrictions and lifespan extension in Nature Communications
* Discovered the effects of the essential amino acid, threonine, on promoting both life and healthspans. * Research findings will be applied to product development of its brand, VITAL BEAUTIE. SEOUL, South Korea, Nov. 8, 2022 /PRNewswire/ -- Amorepacific discovered a mechanism of dietary rest...
XJTLU and University of Liverpool to inaugurate Joint Centre for Pharmacology and Therapeutics
SUZHOU, China, Nov. 8, 2022 /PRNewswire/ -- On 11 November, Xi'an Jiaotong-
Liverpool University (XJTLU) and the University of Liverpool will inaugurate
their Joint Centre for Pharmacology and Therapeutics at an online/onsite event
in Suzhou,China.
Week's Top Stories
Most Reposted
OceanaGold Reports Third Quarter 2026 Results
[Picked up by 1141 media titles]
2026-11-05 06:52Royal Bank of Canada announces agreement to acquire Yarra Capital Management
[Picked up by 1141 media titles]
2026-11-09 21:00Algolia Powers Orange with AI Agents for Billing Support: NYSE Content Update
[Picked up by 1121 media titles]
2026-11-06 22:06Cision Report Reveals the Consumer Trends Hidden Between Search, Social, and AI
[Picked up by 1105 media titles]
2026-11-09 23:00Overstory Launches Integrated AI Platform to Deliver First Living Model of Grid Risk
[Picked up by 1083 media titles]
2026-11-03 22:00